{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:28:12Z","timestamp":1794108492442,"version":"4.8.0"},"reference-count":158,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1124\/dmd.122.001007","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T20:40:14Z","timestamp":1679949614000},"page":"672-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7540-9271","authenticated-orcid":false,"given":"Jing","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6537-5415","authenticated-orcid":false,"given":"Xiao-bo","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.122.001007_bib1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0022-3565(24)39329-2","article-title":"Latent overexpression of hepatic CYP2C7 in adult male and female rats neonatally exposed to phenobarbital: a developmental profile of gender-dependent P450s","volume":"293","author":"Agrawal","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.122.001007_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0026-895X(25)08739-5","article-title":"Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose","volume":"49","author":"Agrawal","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000070460","article-title":"Phenobarbital-imprinted overinduction of adult constituent CYP isoforms","volume":"68","author":"Agrawal","year":"2003","journal-title":"Pharmacology"},{"key":"10.1124\/dmd.122.001007_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1124\/mol.64.3.659","article-title":"Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1","volume":"64","author":"Aklillu","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib5","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1124\/dmd.107.017590","article-title":"Evaluation of the assumptions of an ontogeny model of rat hepatic cytochrome P450 activity","volume":"35","author":"Alcorn","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/15376511003690307","article-title":"The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies","volume":"20","author":"Amacher","year":"2010","journal-title":"Toxicol Mech Methods"},{"key":"10.1124\/dmd.122.001007_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00228-012-1338-y","article-title":"Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care","volume":"69","author":"Andersson","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib8","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/0006-291X(83)90680-0","article-title":"Neonatal phenobarbital administration results in increased cytochrome P450-dependent monooxygenase activity in adult male and female rats","volume":"114","author":"Bagley","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.122.001007_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0041-008X(85)90344-8","article-title":"Neonatal phenobarbital imprinting of hepatic microsomal enzymes in adult rats: modulation by neonatal testosterone presence","volume":"79","author":"Bagley","year":"1985","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"10.1124\/dmd.122.001007_bib11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/dmd.121.000459","article-title":"Alterations of cytochrome P450-mediated drug metabolism during liver repair and regeneration after acetaminophen-induced liver injury in mice","volume":"50","author":"Bao","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/dmd.119.089557","article-title":"Acetaminophen-induced liver injury alters expression and activities of cytochrome P450 enzymes in an age-dependent manner in mouse liver","volume":"48","author":"Bao","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib13","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.3748\/wjg.v13.i42.5635","article-title":"Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse","volume":"13","author":"Baskin-Bey","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1124\/dmd.122.001007_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.0306-5251.2001.01548.x","article-title":"Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs","volume":"53","author":"Bertilsson","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.siny.2004.11.001","article-title":"Ontogeny of drug metabolizing enzymes in the neonate","volume":"10","author":"Blake","year":"2005","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1124\/dmd.122.001007_bib17","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1124\/dmd.109.027482","article-title":"Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis","volume":"37","author":"Bohanec Grabar","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib18","first-page":"612","article-title":"Molecular signals of epigenetic states","volume":"330","author":"Bonasio","year":"2010","journal-title":"Science (1979)"},{"key":"10.1124\/dmd.122.001007_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/dmd.111.040394","article-title":"Effects of omeprazole and genetic polymorphism of CYP2C19 on the clopidogrel active metabolite","volume":"40","author":"Boulenc","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/dmd.119.089755","article-title":"Ontogeny and cross-species comparison of pathways involved in drug absorption, distribution, metabolism, and excretion in neonates (review): kidney","volume":"48","author":"Bueters","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cpt.145","article-title":"Age-related changes in microRNA expression and pharmacogenes in human liver","volume":"98","author":"Burgess","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001007_bib22","first-page":"624","article-title":"Alternative splicing of lncRNAs in human diseases","volume":"11","author":"Chen","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1124\/dmd.122.001007_bib23","first-page":"24","article-title":"The roles of long noncoding RNAs HNF1\u03b1-AS1 and HNF4\u03b1-AS1 in drug metabolism and human diseases","volume":"6","author":"Chen","year":"2020","journal-title":"Noncoding RNA"},{"key":"10.1124\/dmd.122.001007_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1124\/mol.118.112235","article-title":"A transcriptional regulatory network containing nuclear receptors and long noncoding RNAs controls basal and drug-induced expression of cytochrome P450s in HepaRG cells","volume":"94","author":"Chen","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/mol.119.118778","article-title":"Knockdown of long noncoding rnas hepatocyte nuclear factor 1\u03b1 antisense RNA 1 and hepatocyte nuclear factor 4\u03b1 antisense RNA 1 alters susceptibility of acetaminophen-induced cytotoxicity in HepaRG cells","volume":"97","author":"Chen","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/hep.25766","article-title":"Neonatal activation of the nuclear receptor CAR results in epigenetic memory and permanent change of drug metabolism in mouse liver","volume":"56","author":"Chen","year":"2012","journal-title":"Hepatology"},{"key":"10.1124\/dmd.122.001007_bib27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1124\/dmd.106.013748","article-title":"Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat","volume":"35","author":"Cherala","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib28","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/10409238.2020.1828259","article-title":"The molecular structure of long non-coding RNAs: emerging patterns and functional implications","volume":"55","author":"Chill\u00f3n","year":"2020","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1124\/dmd.122.001007_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3727\/105221621X16165282414118","article-title":"Role of noncoding RNAs in acetaminophen-induced liver injury","volume":"20","author":"Chowdhary","year":"2021","journal-title":"Gene Expr"},{"key":"10.1124\/dmd.122.001007_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jcph.23","article-title":"Drug-induced liver injury: the role of drug metabolism and transport","volume":"53","author":"Corsini","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOP.0000000000000338","article-title":"Adverse consequences of neonatal antibiotic exposure","volume":"28","author":"Cotten","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"10.1124\/dmd.122.001007_bib32","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/toxsci\/kfs107","article-title":"RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development","volume":"127","author":"Cui","year":"2012","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.122.001007_bib33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1124\/dmd.111.042697","article-title":"Ontogeny of novel cytochrome P450 gene isoforms during postnatal liver maturation in mice","volume":"40","author":"Cui","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm8010001","article-title":"Pharmacogenomics of CYP2C9: functional and clinical considerations","volume":"8","author":"Daly","year":"2017","journal-title":"J Pers Med"},{"key":"10.1124\/dmd.122.001007_bib35","first-page":"73","article-title":"Drug-induced liver injury","volume":"6","author":"David","year":"2010","journal-title":"US Gastroenterol Hepatol Rev"},{"key":"10.1124\/dmd.122.001007_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","article-title":"Cytochrome P450 3A: ontogeny and drug disposition","volume":"37","author":"de Wildt","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.122.001007_bib37","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/archdischild-2013-305212","article-title":"Drug metabolism for the paediatrician","volume":"99","author":"de Wildt","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1124\/dmd.122.001007_bib38","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.reprotox.2008.09.010","article-title":"The ontogeny of drug metabolizing enzymes and transporters in the rat","volume":"26","author":"de Zwart","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1124\/dmd.122.001007_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4037\/aacnacc2017948","article-title":"Pharmacokinetic changes in liver failure and impact on drug therapy","volume":"28","author":"Diep","year":"2017","journal-title":"AACN Adv Crit Care"},{"key":"10.1124\/dmd.122.001007_bib40","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/jox11030007","article-title":"The central role of cytochrome P450 in xenobiotic metabolism\u2014a brief review on a fascinating enzyme family","volume":"11","author":"Esteves","year":"2021","journal-title":"J Xenobiot"},{"key":"10.1124\/dmd.122.001007_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.286.5439.487","article-title":"Pharmacogenomics: translating functional genomics into rational therapeutics","volume":"286","author":"Evans","year":"1999","journal-title":"Science"},{"key":"10.1124\/dmd.122.001007_bib42","first-page":"719","article-title":"Exposure of newborn rats to pharmacologically active compounds may permanently alter carcinogen metabolism","volume":"211","author":"Faris","year":"1981","journal-title":"Science (1979)"},{"key":"10.1124\/dmd.122.001007_bib43","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1542\/peds.2014-2015","article-title":"Potential drug-drug interactions in infant, child, and adolescent patients in children\u2019s hospitals","volume":"135","author":"Feinstein","year":"2015","journal-title":"Pediatrics"},{"key":"10.1124\/dmd.122.001007_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults","volume":"3","author":"Fernandez","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1124\/dmd.122.001007_bib45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/10408363.2017.1410520","article-title":"Epigenetic biomarkers: current strategies and future challenges for their use in the clinical laboratory","volume":"54","author":"Garc\u00eda-Gim\u00e9nez","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1124\/dmd.122.001007_bib46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/mol.109.062570","article-title":"Crystal structure of a cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-chlorophenyl)imidazole at 2.0-A resolution","volume":"77","author":"Gay","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/hdy.2010.54","article-title":"Epigenetics and gene expression","volume":"105","author":"Gibney","year":"2010","journal-title":"Heredity"},{"key":"10.1124\/dmd.122.001007_bib48","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/dmd.117.078824","article-title":"Clinical pharmacokinetics and the impact of genetic polymorphism on a CYP2C19 substrate, BMS-823778, in healthy subjects","volume":"46","author":"Gong","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202000027","article-title":"From structure to function: route to understanding lncRNA mechanism","volume":"42","author":"Graf","year":"2020","journal-title":"BioEssays"},{"key":"10.1124\/dmd.122.001007_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/j.sempedsurg.2013.10.006","article-title":"Neonatal liver physiology","volume":"22","author":"Grijalva","year":"2013","journal-title":"Semin Pediatr Surg"},{"key":"10.1124\/dmd.122.001007_bib51","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/mt.2015.166","article-title":"Long noncoding RNA CUDR regulates HULC and \u03b2-catenin to govern human liver stem cell malignant differentiation","volume":"23","author":"Gui","year":"2015","journal-title":"Mol Ther"},{"key":"10.1124\/dmd.122.001007_bib52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jbt.2570030408","article-title":"Neonatal phenobarbital imprinting of rat hepatic microsomal testosterone hydroxylations","volume":"3","author":"Haake","year":"1988","journal-title":"J Biochem Toxicol"},{"key":"10.1124\/dmd.122.001007_bib53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13148-015-0136-7","article-title":"Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes","volume":"7","author":"Habano","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1124\/dmd.122.001007_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1479-7364-5-1-61","article-title":"A useful tool for drug interaction evaluation: the University of Washington Metabolism and Transport Drug Interaction Database","volume":"5","author":"Hachad","year":"2010","journal-title":"Hum Genomics"},{"key":"10.1124\/dmd.122.001007_bib55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jad.2019.02.009","article-title":"Moving pharmacoepigenetics tools for depression toward clinical use","volume":"249","author":"Hack","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1124\/dmd.122.001007_bib56","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","article-title":"Inhibition and induction of CYP enzymes in humans: an update","volume":"94","author":"Hakkola","year":"2020","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.122.001007_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/dmd.108.023812","article-title":"Three patterns of cytochrome P450 gene expression during liver maturation in mice","volume":"37","author":"Hart","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FPC.0b013e3282f2f121","article-title":"Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism","volume":"18","author":"Hart","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.122.001007_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.dmpk.2016.08.008","article-title":"Developmental regulation of CYP3A4 and CYP3A7 in Chinese Han population","volume":"31","author":"He","year":"2016","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.122.001007_bib60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jbt.20179","article-title":"Ontogeny of human hepatic cytochromes P450","volume":"21","author":"Hines","year":"2007","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1124\/dmd.122.001007_bib61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1124\/jpet.300.2.355","article-title":"The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes","volume":"300","author":"Hines","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.122.001007_bib62","series-title":"Non-coding RNAs in Colorectal Cancer. Advances in Experimental Medicine and Biology","first-page":"3","article-title":"Non-coding RNAs: classification, biology and functioning","author":"Hombach","year":"2016"},{"key":"10.1124\/dmd.122.001007_bib63","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.117.109744","article-title":"The X-ray crystal structure of the human mono-oxygenase cytochrome P450 3A5-ritonavir complex reveals active site differences between P450s 3A4 and 3A5","volume":"93","author":"Hsu","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib64","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1038\/emm.2017.11","article-title":"Writing, erasing and reading histone lysine methylations","volume":"49","author":"Hyun","year":"2017","journal-title":"Exp Mol Med"},{"key":"10.1124\/dmd.122.001007_bib65","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbrc.2010.02.162","article-title":"Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 system","volume":"396","author":"Ingelman-Sundberg","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.122.001007_bib66","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects","volume":"116","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.122.001007_bib67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2036.1999.00022.x","article-title":"Review article: cytochrome P450 and the metabolism of proton pump inhibitors\u2014emphasis on rabeprazole","volume":"13","author":"Ishizaki","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/dmd.122.001007_bib68","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1124\/dmd.106.012005","article-title":"Phenytoin induction of the cyp2c37 gene is mediated by the constitutive androstane receptor","volume":"34","author":"Jackson","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib69","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/dmd.120.090639","article-title":"Age-related changes in miRNA expression influence GSTZ1 and other drug metabolizing enzymes","volume":"48","author":"Jahn","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib70","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2174\/138920307783018668","article-title":"Molecular mechanisms of cytochrome p450 induction: potential for drug-drug interactions","volume":"8","author":"Jana","year":"2007","journal-title":"Curr Protein Pept Sci"},{"key":"10.1124\/dmd.122.001007_bib71","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.biochi.2012.07.013","article-title":"DNA methylation dynamics in the hepatic CYP3A4 gene promoter","volume":"94","author":"Kacevska","year":"2012","journal-title":"Biochimie"},{"key":"10.1124\/dmd.122.001007_bib72","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.28563","article-title":"DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration","volume":"64","author":"Kaji","year":"2016","journal-title":"Hepatology"},{"key":"10.1124\/dmd.122.001007_bib73","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1073\/pnas.0909344107","article-title":"Histone modification levels are predictive for gene expression","volume":"107","author":"Karli\u0107","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.122.001007_bib74","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0009-9236(03)00225-X","article-title":"Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny","volume":"74","author":"Kearns","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001007_bib75","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1124\/dmd.121.000559","article-title":"Ontogeny of small intestinal drug transporters and metabolizing enzymes based on targeted quantitative proteomics","volume":"49","author":"Kiss","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib76","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3949\/ccjm.78a.10145","article-title":"Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others","volume":"78","author":"Kitzmiller","year":"2011","journal-title":"Cleve Clin J Med"},{"key":"10.1124\/dmd.122.001007_bib77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","article-title":"An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway","volume":"92","author":"Kliewer","year":"1998","journal-title":"Cell"},{"key":"10.1124\/dmd.122.001007_bib78","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41397-017-0011-3","article-title":"The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis","volume":"18","author":"Koonrungsesomboon","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.122.001007_bib79","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/jpet.103.060137","article-title":"Developmental expression of human hepatic CYP2C9 and CYP2C19","volume":"308","author":"Koukouritaki","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.122.001007_bib80","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11357-020-00181-5","article-title":"DNA methylation and histone acetylation changes to cytochrome P450 2E1 regulation in normal aging and impact on rates of drug metabolism in the liver","volume":"42","author":"Kronfol","year":"2020","journal-title":"Geroscience"},{"key":"10.1124\/dmd.122.001007_bib81","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1432-1033.1997.00625.x","article-title":"Expression of CYP3A in the human liver\u2014evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth","volume":"247","author":"Lacroix","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1124\/dmd.122.001007_bib82","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/FPC.0b013e328351d47f","article-title":"PharmGKB summary: very important pharmacogene information for CYP3A5","volume":"22","author":"Lamba","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.122.001007_bib83","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/cpt.2134","article-title":"Impact of hepatic CYP3A4 ontogeny functions on drug-drug interaction risk in pediatric physiologically-based pharmacokinetic\/pharmacodynamic modeling: critical literature review and ivabradine case study","volume":"109","author":"Lang","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001007_bib84","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/00498250600861785","article-title":"Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions","volume":"36","author":"Lee","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.122.001007_bib85","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fgene.2012.00318","article-title":"Clinical application of CYP2C19 pharmacogenetics toward more personalized medicine","volume":"3","author":"Lee","year":"2013","journal-title":"Front Genet"},{"key":"10.1124\/dmd.122.001007_bib86","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1124\/dmd.108.022368","article-title":"Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans","volume":"37","author":"Lee","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib87","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2013.07.001","article-title":"Drug-induced acute liver failure","volume":"17","author":"Lee","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1124\/dmd.122.001007_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018216","article-title":"Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice","volume":"6","author":"Lempi\u00e4inen","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/dmd.122.001007_bib89","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00204-020-02706-5","article-title":"Long noncoding RNA LINC00844-mediated molecular network regulates expression of drug metabolizing enzymes and nuclear receptors in human liver cells","volume":"94","author":"Li","year":"2020","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.122.001007_bib90","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1124\/mol.108.052993","article-title":"Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation","volume":"75","author":"Li","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib91","first-page":"753","article-title":"Cytochrome P450 1A1 and 1B1 promoter CpG island methylation regulates rat liver injury induced by isoniazid","volume":"17","author":"Li","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1124\/dmd.122.001007_bib92","doi-asserted-by":"crossref","first-page":"914","DOI":"10.4161\/epi.21113","article-title":"Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing","volume":"7","author":"Lu","year":"2012","journal-title":"Epigenetics"},{"key":"10.1124\/dmd.122.001007_bib93","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/dmd.112.050211","article-title":"RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice","volume":"41","author":"Lu","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib94","first-page":"187","article-title":"Altered sex differentiation of hepatic ethylmorphine N-demethylation in the male rat following neonatal methadone exposure","volume":"1","author":"Lui","year":"1981","journal-title":"Pediatr Pharmacol (New York)"},{"key":"10.1124\/dmd.122.001007_bib95","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/17425255.2017.1260546","article-title":"Pharmacoepigenetics: an element of personalized therapy?","volume":"13","author":"Majchrzak-Celi\u0144ska","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.122.001007_bib96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1067\/mcp.2000.104736","article-title":"Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation","volume":"67","author":"Manyike","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001007_bib97","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1107\/S2053230X13033141","article-title":"Introduction to protein crystallization","volume":"70","author":"McPherson","year":"2014","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"10.1124\/dmd.122.001007_bib98","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/FPC.0000000000000326","article-title":"Ontogeny-related pharmacogene changes in the pediatric liver transcriptome","volume":"28","author":"Meier","year":"2018","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.122.001007_bib99","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/dmd.122.000859","article-title":"Phenobarbital in nuclear receptor activation: an update","volume":"51","author":"Men","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fphar.2018.00470","article-title":"The ontogeny of cytochrome P450 enzyme activity and protein abundance in conventional pigs in support of preclinical pediatric drug research","volume":"9","author":"Millecam","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/dmd.122.001007_bib102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.2008.177","article-title":"Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period","volume":"85","author":"Mukherjee","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001007_bib103","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1124\/dmd.117.076109","article-title":"Histone modifications regulate the developmental expression of human hepatic UDP-glucuronosyltransferase 1A1","volume":"45","author":"Nie","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib104","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1124\/dmd.120.000195","article-title":"Histone methyltransferase G9a regulates expression of nuclear receptors and cytochrome P450 enzymes in HepaRG cells at basal level and in fatty acid induced steatosis","volume":"48","author":"Pande","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fphar.2014.00103","article-title":"Pharmacogenomics of human P450 oxidoreductase","volume":"5","author":"Pandey","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib106","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1124\/dmd.113.054635","article-title":"RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice","volume":"41","author":"Peng","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114917","article-title":"Developmental programming of long non-coding RNAs during postnatal liver maturation in mice","volume":"9","author":"Peng","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/dmd.122.001007_bib108","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1124\/dmd.112.045088","article-title":"RNA sequencing reveals dynamic changes of mRNA abundance of cytochromes P450 and their alternative transcripts during mouse liver development","volume":"40","author":"Peng","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib109","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2125.1991.tb03873.x","article-title":"Paracetamol poisoning in children and hepatotoxicity","volume":"32","author":"Penna","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40495-016-0078-6","article-title":"Impact of drug treatment at neonatal ages on variability of drug metabolism and drug-drug interactions in adult life","volume":"3","author":"Piekos","year":"2017","journal-title":"Curr Pharmacol Rep"},{"key":"10.1124\/dmd.122.001007_bib111","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1124\/dmd.118.080861","article-title":"Consequences of phenytoin exposure on hepatic cytochrome P450 expression during postnatal liver maturation in mice","volume":"46","author":"Piekos","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/diseases5010011","article-title":"Targeting H19, an imprinted long non-coding RNA, in hepatic functions and liver diseases","volume":"5","author":"Pope","year":"2017","journal-title":"Diseases"},{"key":"10.1124\/dmd.122.001007_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187557","article-title":"The role of H19, a long non-coding RNA, in mouse liver postnatal maturation","volume":"12","author":"Pope","year":"2017","journal-title":"PLoS One"},{"key":"10.1124\/dmd.122.001007_bib114","article-title":"Regulation of nuclear receptors PXR and CAR by small molecules and signal crosstalk: roles in drug metabolism and beyond","author":"Poudel","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib115","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12978","article-title":"lnc-RHL, a novel long non-coding RNA required for the differentiation of hepatocytes from human bipotent progenitor cells","volume":"54","author":"Prabhakar","year":"2021","journal-title":"Cell Prolif"},{"key":"10.1124\/dmd.122.001007_bib116","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jmoldx.2018.01.011","article-title":"Recommendations for clinical CYP2C19 genotyping allele selection: a report of the Association for Molecular Pathology","volume":"20","author":"Pratt","year":"2018","journal-title":"J Mol Diagn"},{"key":"10.1124\/dmd.122.001007_bib117","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/dmd.32.4.367","article-title":"Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals","volume":"32","author":"Riddick","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib118","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1124\/dmd.122.001109","article-title":"Four decades of cytochrome P450 2B research: from protein adducts to protein structures and beyond","volume":"51","author":"Roberts","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib119","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/157488407779422302","article-title":"The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance","volume":"2","author":"Rosemary","year":"2007","journal-title":"Curr Clin Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1708","article-title":"Discovering functional motifs in long noncoding RNAs","volume":"13","author":"Ross","year":"2022","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1124\/dmd.122.001007_bib121","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1124\/dmd.115.068593","article-title":"Hepatic cytochrome P450 activity, abundance, and expression throughout human development","volume":"44","author":"Sadler","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib122","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/dmd.112.048561","article-title":"Intraindividual and interindividual variabilities in endogenous cortisol 6\u03b2-hydroxylation clearance as an index for in vivo CYP3A phenotyping in humans","volume":"41","author":"Shibasaki","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib123","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/bdrc.20199","article-title":"Role of epigenetics in developmental biology and transgenerational inheritance","volume":"93","author":"Skinner","year":"2011","journal-title":"Birth Defects Res C Embryo Today"},{"key":"10.1124\/dmd.122.001007_bib124","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40262-021-01001-5","article-title":"Drug-metabolizing cytochrome P450 enzymes have multifarious influences on treatment outcomes","volume":"60","author":"Song","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.122.001007_bib125","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1124\/dmd.108.021873","article-title":"Developmental changes in human liver CYP2D6 expression","volume":"36","author":"Stevens","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib126","doi-asserted-by":"crossref","DOI":"10.1242\/dev.168146","article-title":"Postnatal liver functional maturation requires Cnot complex-mediated decay of mRNAs encoding cell cycle and immature liver genes","volume":"146","author":"Suzuki","year":"2019","journal-title":"Development"},{"key":"10.1124\/dmd.122.001007_bib127","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1038\/s41598-019-43248-w","article-title":"Transcriptomic profiling identifies novel mechanisms of transcriptional regulation of the cytochrome P450 (Cyp)3a11 gene","volume":"9","author":"Taneja","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.122.001007_bib128","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/genes11111295","article-title":"A review of the important role of CYP2D6 in pharmacogenomics","volume":"11","author":"Taylor","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1124\/dmd.122.001007_bib129","first-page":"243","article-title":"The involvement of miRNAs in CYP450 gene expression: a brief review of the literature","volume":"26","author":"Tezcan","year":"2022","journal-title":"J Res Pharm"},{"key":"10.1124\/dmd.122.001007_bib130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/978-1-0716-1554-6_18","article-title":"Ontogeny of drug-metabolizing enzymes","volume":"2342","author":"Thakur","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.122.001007_bib131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/FPC.0b013e32834c6efd","article-title":"PharmGKB summary: very important pharmacogene information for CYP1A2","volume":"22","author":"Thorn","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.122.001007_bib132","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1124\/dmd.115.066316","article-title":"Dose of phenobarbital and age of treatment at early life are two key factors for the persistent induction of cytochrome P450 enzymes in adult mouse liver","volume":"43","author":"Tien","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib133","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/dmd.116.073601","article-title":"Phenobarbital treatment at a neonatal age results in decreased efficacy of omeprazole in adult mice","volume":"45","author":"Tien","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib134","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/dmd.115.067900","article-title":"Interindividual variability in cytochrome P450-mediated drug metabolism","volume":"44","author":"Tracy","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/dmd.109.029710","article-title":"Genetic variants of CYP3A4 and CYP3A5 in cynomolgus and rhesus macaques","volume":"38","author":"Uno","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib136","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41467-020-20495-4","article-title":"Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization","volume":"12","author":"Uzan-Yulzari","year":"2021","journal-title":"Nat Commun"},{"key":"10.1124\/dmd.122.001007_bib137","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/dmd.115.068726","article-title":"Dynamics of cytosine methylation in the proximal promoters of CYP3A4 and CYP3A7 in pediatric and prenatal livers","volume":"44","author":"Vyhlidal","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib138","doi-asserted-by":"crossref","first-page":"29295","DOI":"10.1074\/jbc.M400580200","article-title":"Human constitutive androstane receptor mediates induction of CYP2B6 gene expression by phenytoin","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.122.001007_bib139","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/dmd.120.000316","article-title":"The long noncoding RNA hepatocyte nuclear factor 4\u03b1 antisense RNA 1 negatively regulates cytochrome P450 enzymes in Huh7 cells via histone modifications","volume":"49","author":"Wang","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib140","article-title":"Epigenetic memory is involved in the persistent alterations of drug-processing genes in adult mice due to PCN-activated PXR during early life","volume":"kfz177","author":"Wang","year":"2019","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.122.001007_bib141","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1124\/dmd.121.000693","article-title":"Long noncoding RNAs hepatocyte nuclear factor 4A antisense RNA 1 and hepatocyte nuclear factor 1A antisense RNA 1 are involved in ritonavir-induced cytotoxicity in hepatoma cells","volume":"50","author":"Wang","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib142","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.apsb.2019.09.011","article-title":"Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance","volume":"10","author":"Wang","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/dmd.122.001007_bib143","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/jpet.118.252940","article-title":"The HNF1\u03b1-regulated LncRNA HNF1\u03b1-AS1 is involved in the regulation of cytochrome P450 expression in human liver tissues and Huh7 cells","volume":"368","author":"Wang","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.122.001007_bib144","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.gde.2009.02.001","article-title":"Characterization of human epigenomes","volume":"19","author":"Wang","year":"2009","journal-title":"Curr Opin Genet Dev"},{"key":"10.1124\/dmd.122.001007_bib145","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1124\/dmd.122.001007_bib146","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ng.154","article-title":"Combinatorial patterns of histone acetylations and methylations in the human genome","volume":"40","author":"Wang","year":"2008","journal-title":"Nat Genet"},{"key":"10.1124\/dmd.122.001007_bib147","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41397-020-0160-7","article-title":"A methylation functional detection hepatic cell system validates correlation between DNA methylation and drug-induced liver injury","volume":"20","author":"Wei","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.122.001007_bib148","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/dmd.122.000857","article-title":"Xenobiotic receptors: a journey of rewards","volume":"51","author":"Xie","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"D1","key":"10.1124\/dmd.122.001007_bib149","doi-asserted-by":"crossref","first-page":"D1200","DOI":"10.1093\/nar\/gkab880","article-title":"DDInter: an online drug-drug interaction database towards improving clinical decision-making and patient safety","volume":"50","author":"Xiong","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.122.001007_bib150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/mol.117.108225","article-title":"Alterations of histone modifications contribute to pregnane X receptor-mediated induction of CYP3A4 by rifampicin","volume":"92","author":"Yan","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.122.001007_bib151","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"Yoon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"10.1124\/dmd.122.001007_bib152","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1517\/17425250903307448","article-title":"Role of microRNAs in the regulation of drug metabolism and disposition","volume":"5","author":"Yu","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.122.001007_bib153","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.apsb.2012.02.011","article-title":"Noncoding microRNAs: small RNAs play a big role in regulation of ADME?","volume":"2","author":"Yu","year":"2012","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/dmd.122.001007_bib154","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/dmd.115.067470","article-title":"MicroRNA pharmacoepigenetics: posttranscriptional regulation mechanisms behind variable drug disposition and strategy to develop more effective therapy","volume":"44","author":"Yu","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/dmd.119.090043","article-title":"Coordinated regulation of UGT2B15 expression by long noncoding RNA LINC00574 and hsa-miR-129-5p in HepaRG cells","volume":"48","author":"Yu","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib156","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.122.001007_bib157","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1124\/dmd.122.000862","article-title":"The function of xenobiotics receptors in metabolic diseases","volume":"51","author":"Zhang","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001007_bib158","doi-asserted-by":"crossref","DOI":"10.1515\/jib-2019-0027","article-title":"Non-coding RNAs and their integrated networks","volume":"16","author":"Zhang","year":"2019","journal-title":"J Integr Bioinform"},{"key":"10.1124\/dmd.122.001007_bib159","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fendo.2019.00764","article-title":"Epigenetic programming and fetal metabolic programming","volume":"10","author":"Zhu","year":"2019","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624009899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624009899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.122.001007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:02:43Z","timestamp":1739955763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624009899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":158,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0090955624009899"],"URL":"https:\/\/doi.org\/10.1124\/dmd.122.001007","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.122.001007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}